Skin and perivascular toxicity induced experimentally by doxorubicin.
Extravasation of antitumor drugs and particularly doxorubicin (DXR) can be followed by skin ulceration and slowly evolving perivascular necrosis. DXR lesions have some characteristics in common with those induced by ionizing radiation and, with respect to gross morphology, are reminiscent of skin lesions induced by necrotizing agents. Time course and histopathology of toxic phenomena induced by intradermal or perivascular injection of various doses of either DXR or caustic chemicals have been studied in hairy outbred and hairless inbred (MF1 hr/hr) mice. The latter strain has been found to be intrinsically more sensitive to DXR induced toxic effects, particularly as far as perivascular administration is concerned. Long lasting lesions and, in a few cases, systemic involvement have been observed. On the contrary, necrotic foci induced by caustic chemicals rapidly regressed in both strains. The perivascular administration model, which has not been previously investigated, appears to be representative of what happens in clinical conditions and can be of use for assessing either skin toxicity of antitumor compound or the protective effect of candidate antidotes.
Balsari
A
A
Inst. of Medical Microbiology, University of Milan, Italy.
Lombardo
N
N
Ghione
M
M
D000818:Animals; D004317:Doxorubicin / Q000008:administration & dosage / Q000633:toxicity*; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000209:etiology* / Q000473:pathology; D005260:Female; D007263:Infusions, Parenteral; D007271:Injections, Intradermal; D051379:Mice; D008812:Mice, Hairless; D009336:Necrosis; D012883:Skin Ulcer / Q000139:chemically induced*; D014652:Vascular Diseases / Q000139:chemically induced* / Q000473:pathology
D004317:Doxorubicin